Showing results (71-80 of 141) with videos related to
Sort By:
Pageof 15
Leukemia & Lymphoma|June 27, 1998
P53 gene mutation in a T-acute lymphoblastic leukemia cell line (loucy) with t(16:20) and 5q- chromosomal aberrationsM Prokocimer, S Peller, H Ben-Bassat, et al.Genomics|December 15, 1996
A novel transcript encoded within the 10-kb first intron of the human p53 tumor suppressor gene (D17S2179E) is induced during differentiation of myeloid leukemia cellsD Reisman, Bálint é, W T Loging, et al.Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|February 1, 1993
c-Myc trans-activates the p53 promoter through a required downstream CACGTG motifD Reisman, N B Elkind, B Roy, et al.Molecular and Cellular Biology|May 1, 1988
p53 increases experimental metastatic capacity of murine carcinoma cellsJ Pohl, N Goldfinger, A Radler-Pohl, et al.Human Mutation|June 20, 1998
Pooled analysis of p53 mutations in hematological malignanciesM Prokocimer, R Unger, H S Rennert, et al.Journal of Virology|October 1, 1996
A p6Pol-protease fusion protein is present in mature particles of human immunodeficiency virus type 1N Almog, R Roller, G Arad, et al.Diabetologia|December 30, 2004
Improved insulin sensitivity and adipose tissue dysregulation after short-term treatment with pioglitazone in non-diabetic, insulin-resistant subjectsA Hammarstedt, V Rotter Sopasakis, S Gogg, et al.FEBS Letters|June 8, 1999
Direct involvement of p53 in the base excision repair pathway of the DNA repair machineryH Offer, R Wolkowicz, D Matas, et al.DNA and Cell Biology|December 1, 1995
A novel polymorphism in intron 6 of the human p53 gene: a possible association with cancer predisposition and susceptibilityS Peller, Y Kopilova, S Slutzki, et al.Cancer Letters|November 18, 2000
Differential sensitivity of MCF-7 and LCC2 cells, to multiple growth inhibitory agents: possible relation to high bcl-2/bax ratio?G Lilling, H Hacohen, J Nordenberg, et al.Pageof 15